Global In Vitro Colorectal Cancer Screening Tests Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Imaging Type;

Colonoscopy, Proctoscopy, CT Scan, Ultrasound, MRI, and PET Scan.

By Application;

MarCarePlex, Cologic, Colox, miRDIGN, PanCDx, and MeSorce CRC.

By Product;

Fecal Occult Blood Tests, Biomarker Tests Market, and CRC DNA Screening Tests.

By End-User;

Hospitals, Clinics, Diagnostics laboratories, and Ambulatory Surgical Centers.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn104938228 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global In Vitro Colorectal Cancer Screening Tests Market (USD Million), 2021 - 2031

In the year 2024, the Global In Vitro Colorectal Cancer Screening Tests Market was valued at USD 10,360.86 million. The size of this market is expected to increase to USD 15,995.12 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.4%.

The global market for in vitro colorectal cancer screening tests is experiencing significant growth, driven by several key factors. Colorectal cancer is among the leading causes of cancer-related deaths worldwide, with early detection being crucial for successful treatment outcomes. In vitro screening tests play a pivotal role in early detection by detecting precancerous lesions or early-stage tumors through the analysis of stool or blood samples. With rising awareness about the importance of regular screenings for colorectal cancer and advancements in diagnostic technologies, the demand for in vitro screening tests is on the rise.

Global market for in vitro colorectal cancer screening tests is the increasing prevalence of colorectal cancer globally. Factors such as sedentary lifestyles, poor dietary habits, and aging populations contribute to the growing incidence of this disease. Consequently, healthcare providers and policymakers are emphasizing the importance of early detection and screening programs, spurring the adoption of in vitro tests as effective tools for population-based screening initiatives.

Vitro diagnostic techniques are driving innovation in colorectal cancer screening. These advancements enable the development of more accurate, sensitive, and user-friendly screening tests, enhancing their utility in both clinical and home settings. Additionally, the growing trend towards personalized medicine is leading to the development of molecular-based screening tests that offer insights into an individual's genetic predisposition to colorectal cancer, further expanding the scope of in vitro screening options. As a result, the global market for in vitro colorectal cancer screening tests is poised for continued growth, with opportunities for manufacturers to develop innovative solutions that address the evolving needs of healthcare systems and patients worldwide.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Imaging Type
    2. Market Snapshot, By Application
    3. Market Snapshot, By Product
    4. Market Snapshot, By End-User
    5. Market Snapshot, By Region
  4. Global In Vitro Colorectal Cancer Screening Tests Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging Population
        2. Increasing Prevalence of Colorectal Cancer
        3. Technological Advancements in Screening Tests
        4. Growing Awareness About Early Cancer Detection
      2. Restrainst
        1. High Cost of Screening Tests
        2. Limited Access to Healthcare Services
        3. Concerns About False Positives and False Negatives
        4. Regulatory Hurdles for Approval of New Tests
      3. Opportunities
        1. Emerging Markets Expansion
        2. Development of Novel Biomarkers
        3. Integration of Artificial Intelligence in Screening
        4. Collaborations for Research and Development
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global In Vitro Colorectal Cancer Screening Tests Market, By Imaging Type, 2021 - 2031 (USD Million)
      1. Colonoscopy
      2. Proctoscopy
      3. CT Scan
      4. Ultrasound
      5. MRI
      6. PET Scan
    2. Global In Vitro Colorectal Cancer Screening Tests Market, By Application, 2021 - 2031 (USD Million)
      1. MarCarePlex
      2. Cologic
      3. Colox
      4. miRDIGN
      5. PanCDx
      6. MeSorce CRC
    3. Global In Vitro Colorectal Cancer Screening Tests Market, By Product, 2021 - 2031 (USD Million)
      1. Fecal Occult Blood Tests
      2. Biomarker Tests market
      3. CRC DNA Screening Tests
    4. Global In Vitro Colorectal Cancer Screening Tests Market, By End-User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinics
      3. Diagnostics laboratories
      4. Ambulatory Surgical Centers
    5. Global In Vitro Colorectal Cancer Screening Tests Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Beckman Coulter Inc
      2. Eiken Chemical
      3. Epigenomics AG Corporation
      4. Sysmex Corporation
      5. Siemens Healthcare Ltd
      6. Quest Diagnostics Incorporated
      7. CompanianDx
      8. OncoCyte Corporation-Biotime
  7. Analyst Views
  8. Future Outlook of the Market